Duloxetine Intermediate and Atorvastatin Intermediates Market Research Report - Forecast till 2030

Duloxetine Intermediate and Atorvastatin Intermediates Market Research Report Information by Intermediate (Duloxetine Intermediates, Atorvastatin Intermediates) and Region - Forecast till 2030

ID: MRFR/HC/6265-CR | 145 Pages | Author: Rahul Gotadki | July 2019         

Duloxetine Atorvastatin Intermediates Market Speak to Analyst Request a Free Sample

Duloxetine Intermediate and Atorvastatin Intermediates Market Overview


The duloxetine intermediate and atorvastatin intermediates market is expected to reach USD 68.12 Million by 2030 at 3.90% CAGR during the forecast period 2022-2030. Duloxetine intermediate is a serotonin-norepinephrine reuptake inhibitor (SNRI) which is widely approved for the treatment of stress urinary incontinence in women, major depressive disorder (MDD), and other chronic diseases. The atorvastatin intermediate is commonly used in lowering the cholesterol level and helps prevent cardiovascular diseases.


Rising prevalence of major depressive disorder (MOD), the growing importance of generics, increasing demand for atorvastatin intermediate, rising incidence of chronic diseases are expected to enhance the duloxetine intermediate and atorvastatin intermediates market growth. However, factors such as increasing healthcare cost and unfavorable drug price control policies across various countries may restrain the duloxetine intermediate and atorvastatin intermediates market growth during the forecast period.


Market Dynamics


The duloxetine intermediate and atorvastatin intermediates market has been primarily driven by the rising prevalence of major depressive disorder (MOD), the growing importance of generics, increasing demand for atorvastatin intermediate, and growing incidence of chronic diseases. For instance, as per the survey carried out by the American Heart Association and the American College of Cardiology in 2016, around 37.5% (43.2 million) to 48.6% (56 million) of the US adults were on treatment by atorvastatin intermediate. Factors such as rising healthcare cost, unfavorable drug price control policies across various countries may restrain the duloxetine intermediate and atorvastatin intermediates market growth during the forecast period.


Global Duloxetine Intermediate and Atorvastatin Intermediates Market Revenue, by Intermediate, 2017 & 2023 (USD Million)  Duloxetine Intermediate & Atorvastatin Intermediates Market


Sources: MRFR Analysis


Segmentation


The duloxetine intermediate and atorvastatin intermediates market is segmented into an intermediate type. Based on intermediate, the market is bifurcated into duloxetine intermediates and atorvastatin intermediates. Duloxetine Intermediate segment held a duloxetine intermediate and atorvastatin intermediates market share of 32393.03 USD Million in 2017.


Key Players


The prominent players in the Duloxetine Intermediate and Atorvastatin Intermediates market are Jiangxi Aifeimu Technology Co., Ltd, Zhejiang Jiuzhou Pharmaceutical Co., Ltd, Jigs Chemicals, Manus Aktteva, Arch Pharmalabs, Afine Chemicals Ltd, Shodhana Laboratories, Fluorochem Ltd, Chiral Bio Sciences Ltd, Tokyo Chemical Industry Co., Ltd.


Asia-Pacific Duloxetine Intermediate and Atorvastatin Intermediates Market Share, 2017 (%)  Duloxetine Intermediate & Atorvastatin Intermediates Market     


Sources: MRFR Analysis


Regional Analysis


The duloxetine intermediate and atorvastatin intermediates market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.


The Americas accounts the largest market share, wherein North America is expected to dominate the market mainly due to the increasing geriatric population and the availability of advanced healthcare facilities in this region.


Europe is anticipated to account for the second-largest market share during the forecast period. The factors responsible for market growth in this region are well-established healthcare infrastructure and the increase in adoption of duloxetine intermediate and atorvastatin intermediates for the treatment of various chronic disease and major mental disorders.


Asia-Pacific is estimated to be the fastest-growing region in the duloxetine intermediate and atorvastatin intermediates market. This can be attributed to developing economies such as China, India, and South Korea emerging as major destinations for the outsourcing of clinical trials, drug manufacturing, and pathology testing. Japan held a market share of 18.5% in 2017.


Also, the duloxetine intermediate and atorvastatin intermediates market in the Middle East and Africa region is projected to account for the least share during the review period. The Middle East is expected to influence the market owing to the increasing use of duloxetine intermediate and atorvastatin intermediates for the treatment of various chronic disorders in Saudi Arabia, Kuwait, and the UAE.


Market Segmentation


Duloxetine Intermediate and Atorvastatin Intermediates Market, by Intermediate Type



  • Duloxetine Intermediates

  • Atorvastatin Intermediates


Duloxetine Intermediate and Atorvastatin Intermediates Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations


Intended Audience



  • Duloxetine intermediate & atorvastatin intermediates manufacturers

  • Healthcare providers

  • Research institutes and academic centers

  • Government associations

  • Market research and consulting

Report Scope:

Report Attribute/Metric Details
  Market Size   68.12 Million
  CAGR   3.90%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Intermediate type
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Jiangxi Aifeimu Technology Co., Ltd, Zhejiang Jiuzhou Pharmaceutical Co., Ltd, Jigs Chemicals, Manus Aktteva, Arch Pharmalabs, Afine Chemicals Ltd, Shodhana Laboratories, Fluorochem Ltd, Chiral Bio Sciences Ltd, Tokyo Chemical Industry Co., Ltd.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising prevalence of major depressive disorder (MOD)
  • Growing importance of generics
  • Increasing demand for atorvastatin intermediate
  • Rising incidence of chronic diseases




  • Frequently Asked Questions (FAQ) :

    Duloxetine intermediate and atorvastatin intermediates market is projected to grow at a 3.90% CAGR between 2022-2030.

    The Americas is expected to dominate the duloxetine intermediate and atorvastatin intermediates market.

    Duloxetine intermediate and atorvastatin intermediates market is predicted to touch USD 68.12 Million by 2030.

    The duloxetine intermediates segment will lead the duloxetine intermediate and atorvastatin intermediates market.

    Rising healthcare cost may restrict duloxetine intermediate and atorvastatin intermediates market growth.

    Key Questions Answered

    • Global Market Outlook
    • In-depth analysis of global and regional trends
    • Analyze and identify the major players in the market, their market share, key developments, etc.
    • To understand the capability of the major players based on products offered, financials, and strategies.
    • Identify disrupting products, companies, and trends.
    • To identify opportunities in the market.
    • Analyze the key challenges in the market.
    • Analyze the regional penetration of players, products, and services in the market.
    • Comparison of major players’ financial performance.
    • Evaluate strategies adopted by major players.
    • Recommendations
    Request Free Sample

    Why Choose Market Research Future?

    • Vigorous research methodologies for specific market.
    • Knowledge partners across the globe
    • Large network of partner consultants.
    • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
    • Trusted by fortune 500 companies/startups/universities/organizations
    • Large database of 5000+ markets reports.
    • Effective and prompt pre- and post-sales support.
    Speak to Analyst
    Leading companies partner with us for data-driven Insights.
    Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

    Kindly complete the form below to receive a free sample of this Report

    Please fill in Business Email for Quick Response
    Invalid